Skip to main content
Advertisement
Advertisement
IVF
IVF logo
INVO Fertility, Inc. Common Stock
2.02
USD
Sponsored
+0.11
+5.76%
Nov 02, 11:52 UTC -5
Open

INVO Fertility, Inc. Common Stock (IVF) Earnings

IVF Earnings Reports

Positive Surprise Ratio

IVF beat 5 of 14 last estimates.

36%

Next Report

Date of Next Report
Nov 16, 2026
Estimate for Q3 26 (Revenue/ EPS)
$2.74M
/
-$0.65
Implied change from Q2 26 (Revenue/ EPS)
+25.80%
/
-75.38%
Implied change from Q3 25 (Revenue/ EPS)
+55.46%
/
-15.58%

INVO Fertility, Inc. Common Stock earnings per share and revenue

On Aug 14, 2026, IVF reported earnings of -2.64 USD per share (EPS) for Q2 26, beating the estimate of -2.82 USD, resulting in a 6.65% surprise. Revenue reached 2.17 million, compared to an expected 2.42 million, with a -10.12% difference. The market reacted with a +57.47% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.65 USD, with revenue projected to reach 2.74 million USD, implying an decrease of -75.38% EPS, and increase of 25.80% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Labcorp Holdings Inc.
Report Date
Oct 28, 2026 For Q3 26
Estimate
$4.79
Actual
$4.78
Surprise
-0.31%
logo
Icon Plc
Report Date
Oct 27, 2026 For Q3 26
Estimate
$2.65
Actual
$2.66
Surprise
+0.27%
logo
BrightSpring Health Services, Inc. Common Stock
Report Date
Oct 30, 2026 For Q3 26
Estimate
$0.48
Actual
$0.54
Surprise
+12.20%
logo
Avantor, Inc.
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.21
Actual
$0.22
Surprise
+3.92%
logo
Bausch + Lomb Corporation
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.22
Actual
$0.34
Surprise
+53.43%
logo
CareDx, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.25
Actual
$0.70
Surprise
+178.44%
logo
Organon & Co.
Report Date
Oct 30, 2026 For Q3 26
Estimate
$0.94
Actual
$0.94
Surprise
-0.73%
logo
Pediatrix Medical Group, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.66
Actual
$0.72
Surprise
+7.61%
logo
Establishment Labs Holdings Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.31
Surprise
-18.41%
logo
Teladoc Health, Inc.
Report Date
Oct 28, 2026 For Q3 26
Estimate
-$0.21
Actual
-$0.15
Surprise
+29.35%
FAQ
For Q2 2026, INVO Fertility, Inc. Common Stock reported EPS of -$2.64, beating estimates by 6.65%, and revenue of $2.17M, -10.12% below expectations.
The stock price moved up 57.47%, changed from $0.97 before the earnings release to $1.53 the day after.
The next earning report is scheduled for Nov 16, 2026.
Based on -- analysts, INVO Fertility, Inc. Common Stock is expected to report EPS of -$0.65 and revenue of $2.74M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement